Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00071617 · ClinicalTrials.gov registry record · Phase 2

Youth-Nominated Support Team Intervention for Suicidal Adolescents

A Phase 2 study of Suicide, Attempted, sponsored by University of Michigan.

Completed
Registry status
Phase 2
Development phase
448
Enrollment target
1
Study location

NCT00071617: Completed Phase 2 study of Suicide, Attempted, sponsored by University of Michigan.

NCT00071617 is a Phase 2 study of Suicide, Attempted that has completed, run by University of Michigan. The registered enrollment target is 448 participants, above the 367-participant average among 36 other Suicide, Attempted trials with a reported enrollment target (22% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00071617, a Phase 2 study of Suicide, Attempted, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
Phase 2
Development phase
448 participants
Enrollment target
1
Study location

Study Summary

This study will attempt to improve treatment adherence and reduce suicide risk among adolescents who are at risk for attempting suicide.

Primary Outcome

Type, frequency, and severity of suicidal thoughts

Conditions Studied

Interventions

  • BEHAVIORAL Youth-Nominated Support Team

Study Locations (1)

Michigan

  • Child and Adolescent Psychiatry Hospital, University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 448 participants
Start Date 2002-11
Est. Completion 2008-12
Phase Phase 2
University of Michigan

1,327 total trials

What the finished NCT00071617 record still lists

NCT00071617 is an interventional study that assigns participants to a tested intervention. The registered 448 participants enrollment target is mid-sized for trials with a published cap, above the 367-participant average among 36 other Suicide, Attempted trials with a reported enrollment target (22% higher).

The record links to 1 condition, with Suicide, Attempted appearing as the primary indexed condition, and to 1 intervention - of which Youth-Nominated Support Team is the first listed.

NCT00071617 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT00071617 about?

NCT00071617 is a clinical study titled "Youth-Nominated Support Team Intervention for Suicidal Adolescents". This study will attempt to improve treatment adherence and reduce suicide risk among adolescents who are at risk for attempting suicide.

What is the current status of trial NCT00071617?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 448 participants. The study started on 2002-11. Estimated completion is 2008-12.

What conditions does trial NCT00071617 study?

This clinical trial studies the following conditions: Suicide, Attempted.

What interventions are being tested in trial NCT00071617?

The interventions under investigation include: Youth-Nominated Support Team (BEHAVIORAL).

Who is sponsoring clinical trial NCT00071617?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00071617 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide, Attempted

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00071617's enrollment target sits among peer trials

448 6th of 36 higher than 31 of 36 other Suicide, Attempted trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicide, Attempted trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06702449 · 448 participants · Phase 1

    A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age

  • NCT07125053 · 448 participants · NA

    COPD Resources, Education, and Activity Designed for You Study

  • NCT04065399 · 447 participants · Phase 1

    A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

  • NCT00515060 · 450 participants

    Psychophysical Studies of Cancer Therapy Pain

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00071617, the US trial registry maintained by the National Library of Medicine. NCT00071617 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.